HDAC9 and cancer: Previously, HDAC inhibitor (HDACi); romidepsin and DNA methyltransferase inhibitor (DNMTi); and 2′-deoxy-5-azacytidine (Decitabine) were used to restore SFRP1 expression in cancer cells (please refer to Section 4 below).